ARCHIVES

Screening Guidelines Differ Among Major Medical Organizations

This article is from The Cancer Letter archive.

Vol. 24 No. 02 | January 16, 1998

Download PDF Visit The Full Archive

Related Articles

FDA Discloses Responses, Toxicities For Burzynski’s “Antineoplastons”

April 24, 1998

Myriad In Partnership To Market Products.

December 14, 2001

NCI Supercomputer Operations To Start In April

November 15, 1985

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

DCE Board Okays New Melanoma Study, Other Concepts

November 11, 1988

Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months

November 4, 1983